1. Home
  2. MAGN vs ABVX Comparison

MAGN vs ABVX Comparison

Compare MAGN & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAGN
  • ABVX
  • Stock Information
  • Founded
  • MAGN 1864
  • ABVX 2013
  • Country
  • MAGN United States
  • ABVX France
  • Employees
  • MAGN N/A
  • ABVX N/A
  • Industry
  • MAGN Paper
  • ABVX
  • Sector
  • MAGN Basic Materials
  • ABVX
  • Exchange
  • MAGN Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • MAGN 626.2M
  • ABVX 722.3M
  • IPO Year
  • MAGN N/A
  • ABVX N/A
  • Fundamental
  • Price
  • MAGN $18.07
  • ABVX $6.16
  • Analyst Decision
  • MAGN
  • ABVX Strong Buy
  • Analyst Count
  • MAGN 0
  • ABVX 7
  • Target Price
  • MAGN N/A
  • ABVX $37.86
  • AVG Volume (30 Days)
  • MAGN 407.0K
  • ABVX 216.6K
  • Earning Date
  • MAGN 02-15-2025
  • ABVX 09-09-2024
  • Dividend Yield
  • MAGN N/A
  • ABVX N/A
  • EPS Growth
  • MAGN N/A
  • ABVX N/A
  • EPS
  • MAGN N/A
  • ABVX N/A
  • Revenue
  • MAGN $2,175,000,000.00
  • ABVX $9,676,417.00
  • Revenue This Year
  • MAGN N/A
  • ABVX $31.67
  • Revenue Next Year
  • MAGN N/A
  • ABVX $759.77
  • P/E Ratio
  • MAGN $30.41
  • ABVX N/A
  • Revenue Growth
  • MAGN N/A
  • ABVX 100.87
  • 52 Week Low
  • MAGN $15.86
  • ABVX $5.54
  • 52 Week High
  • MAGN $35.23
  • ABVX $17.02
  • Technical
  • Relative Strength Index (RSI)
  • MAGN N/A
  • ABVX 30.30
  • Support Level
  • MAGN N/A
  • ABVX $5.54
  • Resistance Level
  • MAGN N/A
  • ABVX $6.46
  • Average True Range (ATR)
  • MAGN 0.00
  • ABVX 0.51
  • MACD
  • MAGN 0.00
  • ABVX -0.04
  • Stochastic Oscillator
  • MAGN 0.00
  • ABVX 30.10

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

Share on Social Networks: